Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease

Pediatric Cardiology

Volumn 24, Issue 2, 2003, Pages 122-126

  Honkanen, V E A ^a   McCrindle, B W ^a   Laxer, R M ^a   Feldman, B M ^a   Schneider, R ^a   Silverman, E D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Coronary arteries; Kawasaki disease

Indexed keywords

ALBUMIN; HEMOGLOBIN; IMMUNOGLOBULIN;

ADOLESCENT; AGE; ARTERITIS; ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HIGH RISK POPULATION; HUMAN; INFANT; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK FACTOR; SEX DIFFERENCE; THROMBOCYTE COUNT;

ADOLESCENT; AGE DISTRIBUTION; C-REACTIVE PROTEIN; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; CORONARY ANEURYSM; CORONARY VESSELS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME; VASCULITIS;

EID: 0042244211     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-002-0063-1     Document Type: Article

References (31)

1. Barron KS, Murphy DJ Jr, Silverman ED, et al. (1990) Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin. J Pediatr 117:638-644
2. Barron KS, Shulman ST, Rowley A, et al. (1999) Report of the National Institutes of Health Workshop on Kawasaki Disease. J Rheumatol 26:170-190
3. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW (1998) A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 81:1116-1120
4. Burns JC, Wiggins Jr JW, Toews WH, et al. (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759-763
5. Chow YM, Lin CY, Hwang B (1993) Serum and urinary interleukin-6 (IL-6) levels as predicting factors of Kawasaki disease activity. Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 34:77-83
6. Cook DH, Antia A, Attie F, et al. (1989) Results from an international survey of Kawasaki disease in 1979-82. Can J Cardiol 5:389-394
7. Daniels SR, Specker B, Capannari TE, et al. (1987) Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. Am J Dis Child 141:205-207
8. Davies MJ, Gordon JL, Gearing AJ, et al. (1993) The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171:223-229
9. de Zorzi A, Colan SD, Gauvreau K, et al. (1998) Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 133:254-258
10. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057-1061
11. Furusho K, Kamiya T, Nakano H, et al. (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055-1058
12. Gersony WM (1998) Predicting coronary aneurysms in Kawasaki disease. Am J Cardiol 81:1162-1164
13. Harada K (1991) Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805-810
14. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178-222
15. Kegel SM, Dorsey TJ, Rowen M, Taylor WF (1977) Cardiac death in mucocutaneous lymph node syndrome. Am J Cardiol 40:282-286
16. Koren G, Lavi S, Rose V, Rowe R (1986) Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108:388-392
17. Koyanagi H, Nakamura Y, Yanagawa H (1998) Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease. Acta Paediatr 87:32-36
18. Koyanagi H, Yanagawa H, Nakamura Y, Yashiro M (1997) Leukocyte counts in patients with Kawasaki disease: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 86:1328-1332
19. Laupland KB, Dele Davies H (1999) Epidemiology, etiology, and management of Kawasaki disease: state of the art. Pediatr Cardiol 20:177-183
20. Lu CP, Lee WJ, Ho MM, Hwang KC (1993) Risk factors of coronary arterial aneurysm in Kawasaki disease. Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 34:173-180
21. Nakano H (1987) Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy. Prog Clin Biol Res 250:287-297
22. Nakano H, Ueda K, Saito A, et al. (1986) Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am J Cardiol 58:739-742
23. Nakano M (1987) Predictive factors of coronary aneurysm in Kawasaki disease - correlation between coronary arterial lesions and serum albumin, cholinesterase activity, prealbumin, retinol-binding protein and immature neutrophils. Prog Clin Biol Res 250:535-537
24. Newburger JW, Takahashi M, Beiser AS, et al. (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
25. Newburger JW, Takahashi M, Burns JC, et al. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347
26. Radford DJ, Sondheimer HM, Williams GJ, Fowler RS (1976) Mucocutaneous lymph node syndrome with coronary artery aneurysm. Am J Dis Child 130:596-598
27. Sato N, Sugimura T, Akagi T, et al. (1999) Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness. Pediatr Int 41:1-7
28. Shackelford PG, Strauss AW (1991) Kawasaki syndrome. N Engl J Med 324:1664-1666
29. Suzuki Y, Iijima M, Sasaki H, et al. (1999) Tachycardia as a potential risk indicator for coronary arterial lesions in Kawasaki disease. Eur J Pediatr 158:207-209
30. Takahashi K, Oharaseki T, Naoe S (2001) Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol 22:138-142
31. Taubert KA, Rowley AH, Shulman ST (1991) Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119:279-282